Does Vyvanse (lisdexamfetamine) affect sexual function or libido in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Does Vyvanse Affect Sexual Function?

Yes, Vyvanse (lisdexamfetamine) can affect sexual function in adults, with erectile dysfunction occurring in 2.6% of males and decreased libido in 1.4% of patients in controlled trials, though emerging evidence suggests it may paradoxically improve certain aspects of sexual function in some individuals. 1

Sexual Side Effects from FDA-Approved Labeling

The FDA label for Vyvanse provides the most definitive data on sexual adverse effects:

  • Erectile dysfunction was observed in 2.6% of males taking lisdexamfetamine versus 0% on placebo in adult ADHD trials 1
  • Decreased libido occurred in 1.4% of subjects on lisdexamfetamine versus 0% on placebo 1
  • These effects were documented in controlled 4-week trials with doses ranging from 30-70 mg daily 1

Mechanism of Sexual Effects

Vyvanse is a prodrug converted to d-amphetamine, which increases dopamine and norepinephrine in the synaptic cleft through reuptake inhibition and promotion of neurotransmitter release 2, 3. These neurotransmitters play complex roles in sexual function:

  • Dopamine is generally associated with sexual desire and arousal, but excessive stimulation or altered neurotransmitter balance may paradoxically impair function 2
  • Norepinephrine elevation can cause vasoconstriction, potentially affecting erectile function 2
  • The sympathetic nervous system activation from amphetamines may interfere with the parasympathetic-mediated processes required for arousal and erection 3

Paradoxical Improvement in Sexual Function

Emerging research suggests Vyvanse may actually improve certain sexual dysfunctions in specific contexts:

  • In a double-blind randomized trial of 46 males with early ejaculation, lisdexamfetamine 30 mg improved dimensions of early ejaculation when taken approximately 6 hours before intercourse, though placebo effects were also significant 4
  • The improvement in ejaculatory control may relate to increased serotonergic and noradrenergic activity, which are known to delay ejaculation 4

Comparison to Other Stimulants

Methylphenidate, another ADHD stimulant, demonstrates similar complex effects on sexual function:

  • Can cause both negative effects (decreased libido, ejaculation disorders) and positive effects (enhanced arousal and performance) depending on individual patient profiles, psychiatric comorbidities, and dosage 5
  • Lower doses and patients with preexisting sexual dysfunction may experience improvements, while higher doses and those with psychiatric comorbidities may experience worsening 5

Clinical Assessment and Management

When evaluating sexual dysfunction in patients taking Vyvanse:

  • Establish temporal relationship: Determine if sexual dysfunction began or worsened after starting Vyvanse versus preexisting issues 1
  • Assess baseline function: ADHD itself is associated with relationship difficulties and may affect sexual function independent of medication 3
  • Consider dose-response: Sexual side effects may be dose-dependent, with higher doses (70 mg) potentially carrying greater risk 1
  • Evaluate psychiatric comorbidities: Depression and anxiety, common in ADHD patients, independently cause sexual dysfunction and may confound attribution 5, 6

Management Strategies

If sexual dysfunction occurs on Vyvanse:

  1. Dose adjustment: Consider reducing to the lowest effective dose (30-50 mg) as sexual side effects may be dose-related 1
  2. Timing modification: Since Vyvanse has a duration of 10-14 hours, taking it earlier in the day may reduce effects during evening sexual activity 3
  3. Switch to alternative stimulant: Consider methylphenidate-based medications (Ritalin, Concerta), which have different mechanisms and may have different sexual side effect profiles 7
  4. Switch to non-stimulant: Atomoxetine, guanfacine, or bupropion represent alternatives if stimulant-related sexual dysfunction is intolerable 8

Important Caveats

  • Baseline sexual dysfunction is common: Sexual dysfunction occurs in 30-100% of psychiatric patients, with depression itself causing decreased libido, arousal difficulties, and anorgasmia independent of medication 6
  • Placebo effects are significant: In the early ejaculation trial, improvements occurred in both lisdexamfetamine and placebo groups, highlighting the role of psychological factors and expectations 4
  • Individual variability: The same medication may impair function in some patients while improving it in others, depending on baseline sexual function, psychiatric comorbidities, dose, and individual neurochemistry 5, 4

References

7
Guideline

Switching from Vyvanse to Adderall for ADHD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

8
Guideline

Combining Amphetamine-Based Stimulants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Are there any drug interactions or safety concerns for a patient taking propranolol 40 mg daily together with lisdexamfetamine (Vyvanse) 70 mg daily, dexamfetamine 5 mg six times daily, olanzapine 2.5 mg nightly, and fluorometholone 0.1% eye drops?
Is it appropriate to increase the dose of Vyvanse (lisdexamfetamine) in a patient who has been taking 30mg for one week and is requesting a dose increase?
A 47-year-old woman taking lisdexamfetamine (Vyvanse) 40 mg daily presents with extreme irritability and difficulty regulating mood; what is the appropriate management?
How can I safely transition a patient on Adderall (dextroamphetamine‑amphetamine) 5 mg once daily to Vyvanse (lisdexamfetamine), including appropriate initial dose, titration schedule, and necessary cardiovascular and psychiatric monitoring?
Are aphthous ulcers associated with the use of Vyvanse (lisdexamfetamine)?
What radiographic features differentiate degenerative joint disease (osteoarthritis) from osteomyelitis, and what are the recommended next steps for diagnosis and management?
What non‑hormonal vaginal moisturizers are available for a postmenopausal woman with vaginal dryness and spotting?
What is the recommended adult dose of mosapride citrate for functional dyspepsia, gastro‑oesophageal reflux disease, chronic gastritis, or gastroparesis, and how should dosing be adjusted in elderly patients or those with moderate renal impairment?
What is the 10‑year ASCVD risk category for a 55‑year‑old man with stage 1 hypertension (clinic blood pressure 140/90 mm Hg, home blood pressure ≤130/85 mm Hg), normal renal function, normal complete blood count, HbA1c 4.4 % and no lipid profile available?
What is the recommended dosing schedule for switching a patient from Abilify (aripiprazole) to Rexulti (brexpiprazole), including those on ≥10 mg daily?
What is the maximum recommended dose of zopiclone for adults, and how does it differ for patients aged ≥65 years, those with hepatic impairment, or those who are particularly sensitive to sedatives?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.